Matt Herman Pledges Support to Groundbreaking Research Benefiting Brain-Injured Children Through Doman International
TAMARAC, FL / ACCESS Newswire / June 17, 2025 /Philanthropist and entrepreneur Matt Herman has announced his support for an important research initiative led by Doman International, a pioneering organization dedicated to transforming the lives of brain-injured children through evidence-based neurological rehabilitation programs.
Matt Herman 's support will help fund the final phase of a critical research project aimed at validating the Doman Developmental Profile, a revolutionary tool designed to assess neurological development in children with brain injuries. This research stands to not only enhance the quality of care for thousands of children globally but also to position the Profile for broad clinical acceptance in hospitals and healthcare systems worldwide.
About Doman International
Doman International (DII) is a globally respected nonprofit dedicated to helping children and adults with neurological conditions, including cerebral palsy, autism, developmental delays, and traumatic brain injuries. The organization was founded on the principles of neuroplasticity-the brain 's ability to change and grow through specific stimulation-and has worked with families from more than 75 countries.
Doman 's program, rooted in over 65 years of applied neuroscience, focuses on comprehensive home-based programs, parental education, and individualized plans that address the root causes of neurological dysfunction. Unlike traditional therapies that may focus on symptoms, Doman International works to retrain the brain itself-enabling individuals to reach levels of ability that were once thought to be impossible.
Thousands of families credit Doman International with giving their children newfound abilities-whether walking, speaking, or even reading-when other systems had given up hope.
Advancing Global Research and Medical Integration
Doman International is currently completing a multi-phase research initiative to scientifically validate its Developmental Profile, a neurological assessment tool used to evaluate over 40,000 children and adults worldwide. The first phase of this research has just been accepted for publication in the International Journal on Disability and Human Development, confirming a remarkable correlation between the Doman Profile and the medically accepted Brunet-Lezine scale.
With just 30-50 additional evaluations needed, the final $25,000 in funding will allow for completion of the remaining phases and subsequent publication. Once validated, the Developmental Profile could be monetized and licensed to mainstream medical institutions, opening the door to widespread adoption in hospitals and clinics-while simultaneously generating a new revenue stream for Doman International to continue its life-changing work.
Matt Herman 's leadership and consideration in supporting this initiative underscores his broader mission to give back through meaningful, measurable impact-especially in causes involving children and neurological development.
Join the Mission
Those interested in joining Matt Herman, Founder and CEO of Enhance Health, in supporting this milestone research may contribute directly to Doman International or help raise the remaining funds through their networks.
"This research isn 't just validating a tool-it 's validating hope for thousands of families," said Herman. "When you help a brain-injured child reach their full potential, you 're not just changing their life-you 're changing the future for everyone who loves them."
To learn more or donate, please visit: www.domaninternational.org
Media Contact:
Doman International
Email: info@domaninternational.org
Website: www.domaninternational.org
SOURCE:Doman International
View the original press release on ACCESS Newswire
© 2025 ACCESS Newswire. All Rights Reserved.
